• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项关于利用基于灌注的磁共振成像鉴别胶质瘤分级和突变状态的系统评价与荟萃分析。

A systematic review and meta-analysis on the differentiation of glioma grade and mutational status by use of perfusion-based magnetic resonance imaging.

作者信息

van Santwijk Lusien, Kouwenberg Valentina, Meijer Frederick, Smits Marion, Henssen Dylan

机构信息

Department of Medical Imaging, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 EZ, Nijmegen, The Netherlands.

Department of Radiology and Nuclear Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.

出版信息

Insights Imaging. 2022 Jun 7;13(1):102. doi: 10.1186/s13244-022-01230-7.

DOI:10.1186/s13244-022-01230-7
PMID:35670981
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9174367/
Abstract

BACKGROUND

Molecular characterization plays a crucial role in glioma classification which impacts treatment strategy and patient outcome. Dynamic susceptibility contrast (DSC) and dynamic contrast enhanced (DCE) perfusion imaging have been suggested as methods to help characterize glioma in a non-invasive fashion. This study set out to review and meta-analyze the evidence on the accuracy of DSC and/or DCE perfusion MRI in predicting IDH genotype and 1p/19q integrity status.

METHODS

After systematic literature search on Medline, EMBASE, Web of Science and the Cochrane Library, a qualitative meta-synthesis and quantitative meta-analysis were conducted. Meta-analysis was carried out on aggregated AUC data for different perfusion metrics.

RESULTS

Of 680 papers, twelve were included for the qualitative meta-synthesis, totaling 1384 patients. It was observed that CBV, ktrans, Ve and Vp values were, in general, significantly higher in IDH wildtype compared to IDH mutated glioma. Meta-analysis comprising of five papers (totaling 316 patients) showed that the AUC of CBV, ktrans, Ve and Vp were 0.85 (95%-CI 0.75-0.93), 0.81 (95%-CI 0.74-0.89), 0.84 (95%-CI 0.71-0.97) and 0.76 (95%-CI 0.61-0.90), respectively. No conclusive data on the prediction of 1p/19q integrity was available from these studies.

CONCLUSIONS

Future research should aim to predict 1p/19q integrity based on perfusion MRI data. Additionally, correlations with other clinically relevant outcomes should be further investigated, including patient stratification for treatment and overall survival.

摘要

背景

分子特征在胶质瘤分类中起着关键作用,这会影响治疗策略和患者预后。动态磁敏感对比(DSC)和动态对比增强(DCE)灌注成像已被提议作为以非侵入性方式帮助表征胶质瘤的方法。本研究旨在回顾和荟萃分析关于DSC和/或DCE灌注MRI预测异柠檬酸脱氢酶(IDH)基因型和1p/19q完整性状态准确性的证据。

方法

在对Medline、EMBASE、科学网和考克兰图书馆进行系统文献检索后,进行了定性荟萃综合分析和定量荟萃分析。对不同灌注指标的汇总曲线下面积(AUC)数据进行荟萃分析。

结果

在680篇论文中,12篇被纳入定性荟萃综合分析,共1384例患者。观察到,与IDH突变型胶质瘤相比,IDH野生型胶质瘤的脑血容量(CBV)、传递常数(ktrans)、血管外细胞外间隙容积分数(Ve)和血浆容积分数(Vp)值总体上显著更高。由五篇论文(共316例患者)组成的荟萃分析表明,CBV、ktrans、Ve和Vp的AUC分别为0.85(95%置信区间0.75 - 0.93)、0.81(95%置信区间0.74 - 0.89)、0.84(95%置信区间0.71 - 0.97)和0.76(95%置信区间0.61 - 0.90)。这些研究没有关于预测1p/19q完整性的确凿数据。

结论

未来的研究应旨在基于灌注MRI数据预测1p/19q完整性。此外,应进一步研究与其他临床相关结果的相关性,包括治疗的患者分层和总生存期。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f51/9174367/f24433b35b8b/13244_2022_1230_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f51/9174367/c3d31ddf1e87/13244_2022_1230_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f51/9174367/f24433b35b8b/13244_2022_1230_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f51/9174367/c3d31ddf1e87/13244_2022_1230_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f51/9174367/f24433b35b8b/13244_2022_1230_Fig2_HTML.jpg

相似文献

1
A systematic review and meta-analysis on the differentiation of glioma grade and mutational status by use of perfusion-based magnetic resonance imaging.一项关于利用基于灌注的磁共振成像鉴别胶质瘤分级和突变状态的系统评价与荟萃分析。
Insights Imaging. 2022 Jun 7;13(1):102. doi: 10.1186/s13244-022-01230-7.
2
Static F-FET PET and DSC-PWI based on hybrid PET/MR for the prediction of gliomas defined by IDH and 1p/19q status.基于静态 F-FET PET 和 DSC-PWI 的 IDH 和 1p/19q 状态定义的胶质瘤的杂交 PET/MR 预测。
Eur Radiol. 2021 Jun;31(6):4087-4096. doi: 10.1007/s00330-020-07470-9. Epub 2020 Nov 19.
3
Perfusion MRI grading diffuse gliomas: Impact of permeability parameters on molecular biomarkers and survival.灌注磁共振成像对弥漫性胶质瘤的分级:通透性参数对分子生物标志物和生存的影响
Neurocirugia (Astur : Engl Ed). 2019 Jan-Feb;30(1):11-18. doi: 10.1016/j.neucir.2018.06.004. Epub 2018 Aug 22.
4
Application of Cluster Analysis of Time Evolution for Magnetic Resonance Imaging -Derived Oxygen Extraction Fraction Mapping: A Promising Strategy for the Genetic Profile Prediction and Grading of Glioma.基于磁共振成像衍生的氧提取分数图谱的时间演化聚类分析的应用:一种用于胶质瘤基因特征预测和分级的有前景的策略。
Front Neurosci. 2021 Oct 4;15:736891. doi: 10.3389/fnins.2021.736891. eCollection 2021.
5
Predicting 1p/19q codeletion status using diffusion-, susceptibility-, perfusion-weighted, and conventional MRI in IDH-mutant lower-grade gliomas.使用弥散加权成像、磁敏感加权成像、灌注加权成像和常规 MRI 预测 IDH 突变型低级别胶质瘤的 1p/19q 共缺失状态。
Acta Radiol. 2021 Dec;62(12):1657-1665. doi: 10.1177/0284185120973624. Epub 2020 Nov 22.
6
Multi-parametric Z-spectral MRI may have a good performance for glioma stratification in clinical patients.多参数 Z 谱 MRI 可能在临床患者的胶质瘤分层中具有良好的性能。
Eur Radiol. 2022 Jan;32(1):101-111. doi: 10.1007/s00330-021-08175-3. Epub 2021 Jul 17.
7
Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.动态对比增强和动态磁敏感对比灌注磁共振成像用于胶质瘤分级:使用热点和直方图分析对血管腔室和通透性参数的初步比较
Eur J Radiol. 2016 Jun;85(6):1147-56. doi: 10.1016/j.ejrad.2016.03.020. Epub 2016 Mar 22.
8
IDH mutant and 1p/19q co-deleted oligodendrogliomas: tumor grade stratification using diffusion-, susceptibility-, and perfusion-weighted MRI.异柠檬酸脱氢酶(IDH)突变型和1p/19q共缺失的少突胶质细胞瘤:利用扩散加权磁共振成像、磁敏感加权成像和灌注加权磁共振成像进行肿瘤分级分层
Neuroradiology. 2017 Jun;59(6):555-562. doi: 10.1007/s00234-017-1839-6. Epub 2017 May 4.
9
DSC and DCE Histogram Analyses of Glioma Biomarkers, Including IDH, MGMT, and TERT, on Differentiation and Survival.DSC 和 DCE 直方图分析胶质瘤生物标志物,包括 IDH、MGMT 和 TERT,用于分化和生存。
Acad Radiol. 2020 Dec;27(12):e263-e271. doi: 10.1016/j.acra.2019.12.010. Epub 2020 Jan 23.
10
The T2-FLAIR-mismatch sign as an imaging biomarker for IDH and 1p/19q status in diffuse low-grade gliomas: a systematic review with a Bayesian approach to evaluation of diagnostic test performance.T2-FLAIR 错配征象作为弥漫性低级别胶质瘤 IDH 和 1p/19q 状态的影像学生物标志物:一项基于贝叶斯方法评估诊断试验性能的系统评价。
Neurosurg Focus. 2019 Dec 1;47(6):E13. doi: 10.3171/2019.9.FOCUS19660.

引用本文的文献

1
Differentiation of Molecular Glioblastomas and Lower-grade Diffuse Astrocytomas Using MRI Perfusion and Diffusion Parameters.利用磁共振成像灌注和扩散参数鉴别分子型胶质母细胞瘤和低级别弥漫性星形细胞瘤
Clin Neuroradiol. 2025 Aug 20. doi: 10.1007/s00062-025-01550-3.
2
Role of dynamic contrast-enhanced and dynamic susceptibility contrast imaging in evaluating the biological features of glioma.动态对比增强成像和动态磁敏感对比成像在评估胶质瘤生物学特征中的作用。
Quant Imaging Med Surg. 2025 Aug 1;15(8):7030-7045. doi: 10.21037/qims-2024-2794. Epub 2025 Jul 28.
3
Does arterial spin labelling represent a valid alternative to other MR perfusion techniques in neuro-oncology?

本文引用的文献

1
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.2021 年世卫组织中枢神经系统肿瘤分类:概述。
Neuro Oncol. 2021 Aug 2;23(8):1231-1251. doi: 10.1093/neuonc/noab106.
2
Accuracy of Machine Learning Algorithms for the Classification of Molecular Features of Gliomas on MRI: A Systematic Literature Review and Meta-Analysis.用于基于MRI对胶质瘤分子特征进行分类的机器学习算法的准确性:一项系统文献综述和荟萃分析
Cancers (Basel). 2021 May 26;13(11):2606. doi: 10.3390/cancers13112606.
3
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood.
在神经肿瘤学中,动脉自旋标记是否是其他磁共振灌注技术的有效替代方法?
Radiol Med. 2025 Jul 15. doi: 10.1007/s11547-025-02048-1.
4
The Value of Cerebral Blood Volume Derived from Dynamic Susceptibility Contrast Perfusion MRI in Predicting IDH Mutation Status of Brain Gliomas-A Systematic Review and Meta-Analysis.基于动态磁敏感对比灌注磁共振成像的脑血容量在预测脑胶质瘤异柠檬酸脱氢酶突变状态中的价值——一项系统评价和荟萃分析
Diagnostics (Basel). 2025 Apr 1;15(7):896. doi: 10.3390/diagnostics15070896.
5
Integrating quantitative DCE-MRI parameters and radiomic features for improved IDH mutation prediction in gliomas.整合定量动态对比增强磁共振成像(DCE-MRI)参数和影像组学特征以改善胶质瘤中异柠檬酸脱氢酶(IDH)突变预测
Front Oncol. 2025 Mar 11;15:1530144. doi: 10.3389/fonc.2025.1530144. eCollection 2025.
6
Research Progress on Glioma Microenvironment and Invasiveness Utilizing Advanced Multi-Parametric Quantitative MRI.利用先进的多参数定量磁共振成像对胶质瘤微环境与侵袭性的研究进展
Cancers (Basel). 2024 Dec 29;17(1):74. doi: 10.3390/cancers17010074.
7
Impact of Sex Hormones on Glioblastoma: Sex-Related Differences and Neuroradiological Insights.性激素对胶质母细胞瘤的影响:性别差异与神经放射学见解
Life (Basel). 2024 Nov 21;14(12):1523. doi: 10.3390/life14121523.
8
Distributed parameter model of dynamic contrast-enhanced MRI in the identification of IDH mutation, 1p19q codeletion, and tumor cell proliferation in glioma patients.动态对比增强磁共振成像的分布参数模型在胶质瘤患者异柠檬酸脱氢酶(IDH)突变、1p19q共缺失及肿瘤细胞增殖识别中的应用
Front Oncol. 2024 Oct 25;14:1333798. doi: 10.3389/fonc.2024.1333798. eCollection 2024.
9
Beyond T2-FLAIR mismatch sign in isocitrate dehydrogenase mutant 1p19q non-codeleted astrocytoma: Analysis of tumor core and evolution with multiparametric magnetic resonance imaging.异柠檬酸脱氢酶突变型1p19q非共缺失星形细胞瘤中超越T2-FLAIR不匹配征象的研究:基于多参数磁共振成像的肿瘤核心及演变分析
Neurooncol Adv. 2024 Jul 18;6(1):vdae065. doi: 10.1093/noajnl/vdae065. eCollection 2024 Jan-Dec.
10
Diffuse glioma molecular profiling with arterial spin labeling and dynamic susceptibility contrast perfusion MRI: A comparative study.利用动脉自旋标记和动态对比增强灌注磁共振成像对弥漫性胶质瘤进行分子特征分析:一项比较研究。
Neurooncol Adv. 2024 Jul 5;6(1):vdae113. doi: 10.1093/noajnl/vdae113. eCollection 2024 Jan-Dec.
EANO 成人弥漫性胶质瘤诊断与治疗指南。
Nat Rev Clin Oncol. 2021 Mar;18(3):170-186. doi: 10.1038/s41571-020-00447-z. Epub 2020 Dec 8.
4
Machine learning assisted DSC-MRI radiomics as a tool for glioma classification by grade and mutation status.机器学习辅助 DSC-MRI 放射组学作为一种基于分级和突变状态对胶质瘤进行分类的工具。
BMC Med Inform Decis Mak. 2020 Jul 6;20(1):149. doi: 10.1186/s12911-020-01163-5.
5
Simplified perfusion fraction from diffusion-weighted imaging in preoperative prediction of IDH1 mutation in WHO grade II-III gliomas: comparison with dynamic contrast-enhanced and intravoxel incoherent motion MRI.术前基于弥散加权成像简化灌注分数对 IDH1 突变型 WHO Ⅱ-Ⅲ级脑胶质瘤的预测:与动态对比增强和体素内不相干运动 MRI 的比较。
Radiol Oncol. 2020 Jun 19;54(3):301-310. doi: 10.2478/raon-2020-0037.
6
Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas.用于高级别脑胶质瘤的动态对比磁共振成像协议的共识建议。
Neuro Oncol. 2020 Sep 29;22(9):1262-1275. doi: 10.1093/neuonc/noaa141.
7
Association of dynamic susceptibility magnetic resonance imaging at initial tumor diagnosis with the prognosis of different molecular glioma subtypes.初始肿瘤诊断时的动态磁敏感加权磁共振成像与不同分子亚型胶质瘤预后的相关性
Neurol Sci. 2020 Dec;41(12):3625-3632. doi: 10.1007/s10072-020-04474-7. Epub 2020 May 28.
8
Vascular habitat analysis based on dynamic susceptibility contrast perfusion MRI predicts IDH mutation status and prognosis in high-grade gliomas.基于动态磁敏感对比灌注 MRI 的血管生境分析预测高级别胶质瘤 IDH 突变状态和预后。
Eur Radiol. 2020 Jun;30(6):3254-3265. doi: 10.1007/s00330-020-06702-2. Epub 2020 Feb 20.
9
"Real world" use of a highly reliable imaging sign: "T2-FLAIR mismatch" for identification of IDH mutant astrocytomas.“T2-FLAIR 不匹配”这一高度可靠的影像学征象在 IDH 突变型星形细胞瘤中的“真实世界”应用。
Neuro Oncol. 2020 Jul 7;22(7):936-943. doi: 10.1093/neuonc/noaa041.
10
DSC and DCE Histogram Analyses of Glioma Biomarkers, Including IDH, MGMT, and TERT, on Differentiation and Survival.DSC 和 DCE 直方图分析胶质瘤生物标志物,包括 IDH、MGMT 和 TERT,用于分化和生存。
Acad Radiol. 2020 Dec;27(12):e263-e271. doi: 10.1016/j.acra.2019.12.010. Epub 2020 Jan 23.